Precision Performance Status Compared With ECOG Performance Status

Active, not recruitingOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2026

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Functional Assessment

Undergo chair-to-table assessment

BEHAVIORAL

Timed Get Up and Go Test

"Undergo Get Up and Go assessment"

Trial Locations (2)

90033

Los Angeles General Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER